Kline Ashley Hartmann bought PVLA

February 5, 2026 · Form 4 insider transaction

Kline Ashley Hartmann bought 38,517 shares of Palvella Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
38,517
Price
$0.00
Total value
N/A
Role
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 5, 2026
Filing dateFebruary 9, 2026
Shares owned after38,517
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The shares subject to this option shall vest and become exercisable in equal monthly installments over 48 months commencing from February 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

View the original Form 4 on SEC EDGAR